Table 1.
Characteristics of and treatments for all stage cancer patients
| Characteristics | Total (N = 142 636) | Male (N = 870) | Female (N = 141 766) | P‐value |
|---|---|---|---|---|
| Age, mean (SD, min–max), years | 60 (14, 20‐105) | 70 (12, 27‐95) | 60 (14, 20‐105) | <.001 |
| ≤64, n (%) | 87 530 (61.4) | 257 (29.5) | 87 273 (61.6) | |
| 65‐74, n (%) | 32 743 (22.9) | 272 (31.3) | 32 471 (22.9) | |
| ≥75, n (%) | 22 363 (15.7) | 341 (39.2) | 22 022 (15.5) | |
| Laterality | .012 | |||
| Right, n (%) | 69 932 (49.0) | 421 (48.4) | 69 511 (49.0) | |
| Left, n (%) | 72 560 (50.9) | 447 (51.4) | 72 113 (50.9) | |
| Bilateral, n (%) | 97 (0.07) | 0 (0) | 97 (0.07) | |
| Unknown, n (%) | 47 (0.04) | 2 (0.22) | 45 (0.03) | |
| Combined stage, n (%) | <.001 | |||
| Stage 0 | 17 722 (12.4) | 70 (8.1) | 17 652 (12.5) | |
| Stage I | 56 087 (39.3) | 305 (35.1) | 55 782 (39.4) | |
| Stage II | 46 317 (32.5) | 278 (31.9) | 46 039 (32.5) | |
| Stage III | 15 117 (10.6) | 164 (18.9) | 14 953 (10.6) | |
| Stage IV | 7393 (5.2) | 53 (6.1) | 7340 (5.2) | |
| Breast surgery, n (%) | 130 719 (91.7) | 772 (88.7) | 129 947 (91.7) | .002 |
| Radiation therapy, n (%) | 62 245 (43.6) | 139 (15.9) | 62 106 (43.8) | <.001 |
| Hormone therapy, n (%) | 95 602 (67.0) | 680 (78.2) | 94 922 (66.9) | <.001 |
| Chemotherapy, n (%) | 53 210 (37.3) | 236 (27.1) | 52 974 (37.4) | <.001 |
| Trastuzumab, n (%) | 17 337 (12.2) | 52 (5.9) | 17 285 (12.2) | <.001 |